These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20076792)

  • 1. Acquired heterosubtypic antibodies in human immunity for avian H5N1 influenza.
    Lynch GW; Selleck P; Sullivan JS
    J Mol Genet Med; 2009 Dec; 3(2):205-9. PubMed ID: 20076792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans.
    Lynch GW; Selleck P; Church WB; Sullivan JS
    Immunol Cell Biol; 2012 Feb; 90(2):149-58. PubMed ID: 21647170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.
    Throsby M; van den Brink E; Jongeneelen M; Poon LL; Alard P; Cornelissen L; Bakker A; Cox F; van Deventer E; Guan Y; Cinatl J; ter Meulen J; Lasters I; Carsetti R; Peiris M; de Kruif J; Goudsmit J
    PLoS One; 2008; 3(12):e3942. PubMed ID: 19079604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages.
    Corbett KS; Moin SM; Yassine HM; Cagigi A; Kanekiyo M; Boyoglu-Barnum S; Myers SI; Tsybovsky Y; Wheatley AK; Schramm CA; Gillespie RA; Shi W; Wang L; Zhang Y; Andrews SF; Joyce MG; Crank MC; Douek DC; McDermott AB; Mascola JR; Graham BS; Boyington JC
    mBio; 2019 Feb; 10(1):. PubMed ID: 30808695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.
    Criado MF; Sá E Silva M; Lee DH; Salge CAL; Spackman E; Donis R; Wan XF; Swayne DE
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.
    Cox F; Baart M; Huizingh J; Tolboom J; Dekking L; Goudsmit J; Saeland E; Radošević K
    PLoS One; 2015; 10(12):e0145243. PubMed ID: 26696245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
    Kamlangdee A; Kingstad-Bakke B; Osorio JE
    J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell mediated immunity against influenza H5N1 nucleoprotein, matrix and hemagglutinin derived epitopes in H5N1 survivors and non-H5N1 subjects.
    Noisumdaeng P; Roytrakul T; Prasertsopon J; Pooruk P; Lerdsamran H; Assanasen S; Kitphati R; Auewarakul P; Puthavathana P
    PeerJ; 2021; 9():e11021. PubMed ID: 33854839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterosubtypic anti-avian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell culture.
    Sullivan JS; Selleck PW; Downton T; Boehm I; Axell AM; Ayob Y; Kapitza NM; Dyer W; Fitzgerald A; Walsh B; Lynch GW
    J Mol Genet Med; 2009 Dec; 3(2):217-24. PubMed ID: 20076794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats.
    Straight TM; Ottolini MG; Prince GA; Eichelberger MC
    Virol J; 2008 Mar; 5():44. PubMed ID: 18355405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and predictors for homo- and heterosubtypic antibodies against influenza a virus.
    Kohler I; Scherrer AU; Zagordi O; Bianchi M; Wyrzucki A; Steck M; Ledergerber B; Günthard HF; Hangartner L
    Clin Infect Dis; 2014 Nov; 59(10):1386-93. PubMed ID: 25139962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baculovirus Displaying Hemagglutinin Elicits Broad Cross-Protection against Influenza in Mice.
    Sim SH; Kim JY; Seong BL; Nguyen HH; Chang J
    PLoS One; 2016; 11(3):e0152485. PubMed ID: 27023684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against H5N1 by multiple immunizations with seasonal influenza vaccine in mice is correlated with H5 cross-reactive antibodies.
    Roos A; Roozendaal R; Theeuwsen J; Riahi S; Vaneman J; Tolboom J; Dekking L; Koudstaal W; Goudsmit J; Radošević K
    Vaccine; 2015 Mar; 33(14):1739-47. PubMed ID: 25659276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza.
    Goy K; Von Bibra S; Lewis J; Laurie K; Barr I; Anderson D; Hellard M; Ffrench R
    Influenza Other Respir Viruses; 2008 Jul; 2(4):115-25. PubMed ID: 19453462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.